Cargando…

Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial

CONTEXT: Acetyl-l-carnitine (ALC), a mitochondrial carrier involved in lipid oxidation and glucose metabolism, decreased systolic blood pressure (SBP), and ameliorated insulin sensitivity in hypertensive nondiabetic subjects at high cardiovascular risk. OBJECTIVE: To assess the effects of ALC on SBP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parvanova, Aneliya, Trillini, Matias, Podestà, Manuel A, Iliev, Ilian P, Aparicio, Carolina, Perna, Annalisa, Peraro, Francesco, Rubis, Nadia, Gaspari, Flavio, Cannata, Antonio, Ferrari, Silvia, Bossi, Antonio C, Trevisan, Roberto, Parameswaran, Sreejith, Chávez-Iñiguez, Jonathan S, Masnic, Fahrudin, Seck, Sidy Mohamed, Jiamjariyaporn, Teerayuth, Cortinovis, Monica, Perico, Luca, Sharma, Kanishka, Remuzzi, Giuseppe, Ruggenenti, Piero, Warnock, David G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912091/ https://www.ncbi.nlm.nih.gov/pubmed/29696241 http://dx.doi.org/10.1210/js.2017-00426

Ejemplares similares

Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008)

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
por: Ruggenenti, Piero, et al.
Publicado: (2012)

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
por: Perico, Norberto, et al.
Publicado: (2019)

ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy
por: Rurali, Erica, et al.
Publicado: (2013)

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
por: Valoti, Elisabetta, et al.
Publicado: (2019)

Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
por: Ruggenenti, Piero, et al.
Publicado: (2022)

Long-term follow-up of recovered patients with COVID-19
por: Cortinovis, Monica, et al.
Publicado: (2021)

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Fresh lemon juice supplementation for the prevention of recurrent stones in calcium oxalate nephrolithiasis: A pragmatic, prospective, randomised, open, blinded endpoint (PROBE) trial
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study
por: Ruggenenti, Piero, et al.
Publicado: (2012)

Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
por: Perico, Norberto, et al.
Publicado: (2023)

Calciphylaxis - Case Report
por: Prohic, Nejra, et al.
Publicado: (2020)

A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study
por: Suter, Fredy, et al.
Publicado: (2021)

A Home-Treatment Algorithm Based on Anti-inflammatory Drugs to Prevent Hospitalization of Patients With Early COVID-19: A Matched-Cohort Study (COVER 2)
por: Consolaro, Elena, et al.
Publicado: (2022)

Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
por: Perna, Annalisa, et al.
Publicado: (2022)

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
por: Perico, Norberto, et al.
Publicado: (2018)

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
por: Casiraghi, Federica, et al.
Publicado: (2019)

In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine
por: Munafò, Antonio, et al.
Publicado: (2021)

Correlation Between C-reactive Protein and Non-enzymatic Antioxidants (Albumin, Ferritin, Uric Acid and Bilirubin) in Hemodialysis Patients
por: Beciragic, Amela, et al.
Publicado: (2015)

Issues of Renal Replacement Therapy in Elders Living Low-Income African Countries
por: Seck, Sidy Mohamed
Publicado: (2012)

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
por: Perico, Luca, et al.
Publicado: (2022)

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
por: Sharma, Sanjib Kumar, et al.
Publicado: (2007)

Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Mortality in Hemodialysis Patients Over 65 Years of Age
por: Coric, Aida, et al.
Publicado: (2015)

Sirtuin 3 in acute kidney injury
por: Perico, Luca, et al.
Publicado: (2015)

A comparison of metrics and performance characteristics of different search strategies for article retrieval for a systematic review of the global epidemiology of kidney and urinary diseases
por: Bikbov, Boris, et al.
Publicado: (2018)

Editorial: Global excellence in translational immunology: Europe
por: Casiraghi, Federica, et al.
Publicado: (2023)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Kidney diseases
por: Daina, Erica, et al.
Publicado: (2022)

Editorial: Insights in renal pharmacology: 2021
por: Perico, Norberto, et al.
Publicado: (2022)

A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals
por: Breno, Matteo, et al.
Publicado: (2023)

Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients
por: Spinelli, Letizia, et al.
Publicado: (2018)

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
por: Cravedi, Paolo, et al.
Publicado: (2010)

Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT study): rationale and design of the study [NCT01978951]
por: Jiamjariyaporn, Teerayuth, et al.
Publicado: (2014)

Functional Magnetic Resonance Imaging Versus Kidney Biopsy to Assess Response to Therapy in Nephrotic Syndrome: A Case Report
por: Caroli, Anna, et al.
Publicado: (2020)

A New PKD-1 Mutation Discovered in a Black African Woman With Autosomal Polycystic Kidney Disease
por: Seck, Sidy Mohamed, et al.
Publicado: (2013)

Ranolazine can markedly increase tacrolimus blood levels
por: Seck, Sidy, et al.
Publicado: (2011)

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19
por: Aiello, Sistiana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23b20sq54jf35f8fu12go150jh